BioCentury
ARTICLE | Politics, Policy & Law

As Biden backs WTO IP waiver for COVID vaccines, debate focuses on precedent, not access

May 6, 2021 12:54 AM UTC

The biopharma industry condemned, and a wide range of politicians and global health advocates praised, the Biden administration’s decision to support a WTO waiver of IP protections for COVID-19 ...



Access this Article